跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 95,761 条关于
“Rho-associated coiled-coil kinase 2”
全部
95,761
临床试验
64,639
药物
8,588
机构
1,583
资讯
20,951
11个月前
European Regulators Reject Sanofi's Rezurock for Chronic Graft-vs-Host Disease Treatment
4年前
FDA Approves Belumosudil for Chronic Graft-Versus-Host Disease Treatment
5年前
ROCK2 Inhibition With Belumosudil (KD025) Shows Promise in Treating Chronic Graft-Versus-Host Disease
3个月前
Landmark Cell Study Identifies ROCK2 as Precision Target; TDI01 Demonstrates Liver Fibrosis Reversal in Early Clinical Data
2年前
Belumosudil Shows Promise in Chinese Patients with Chronic Graft-versus-Host Disease
去年
Belumosudil Shows Promise in Treating Heavily Pretreated Chronic Graft-versus-Host Disease
上个月
Graviton BioScience Secures FDA IND Clearance for GV101, a Novel ROCK2 Inhibitor for Friedreich's Ataxia
11个月前
Redx Pharma's Zelasudil Shows Promise in Phase 2a IPF Trial with 47% Reduction in Lung Function Decline
6个月前
Roquefort Therapeutics Acquires TACC3 Inhibitor AO-252 in £31.9M Deal, Rebrands as Coiled Therapeutics
去年
Genomenon and UCB Partner to Advance Thymidine Kinase 2 Deficiency Diagnosis Through Genomic Intelligence
第 1 页，共 2096 页
上一页
下一页
